PRACTICE Reliability for our customers: we are prepared At HARTMANN, we take a proactive approach. By preparing well in advance for BPR authorization, we can avoid delays, secure market access and provide our customers with reliable support. We understand that regulatory changes can be complex and may require adjustments to formulations, product names, labels, item numbers or authorizations, for example. However, this should not cause our customers unnecessary concern. How do we ensure this? We carefully manage these adjustments, providing information about them early on in a transparent manner, and we offer our customers safe, effective and legally compliant disinfection solutions. Sources 1. https://echa.europa.eu/de/regulations/biocidal-products-regulation/understanding-bpr (accessed on 25 August 2026) 2. https://www.bvmed.de/themen/nachhaltigkeit/environmental-law-information-service/enviormental-law-overview-biocide-regulation (accessed on 25 August 2026) 3. Kramer A et al. (2023) GMS Hyg Infect Control 18: Doc02. https://doi.org/10.3205/dgkh000428. Key points at a glance: • The EU Biocidal Products Regulation (BPR) ensures a high level of protection for humans, animals and the environment. • HARTMANN is keeping pace with regulatory changes through the #DrivenByBPR campaign – transparently and with a focus on the customer. • Products such as Sterillium® pure are already BPR-approved and offer a reliable, effective and legally compliant solution. #Driven by BPR: Find out more on the campaign website and watch the video! https://www.hartmann. info/en/campaign/ disinfection/2026/bpr First HARTMANN products already BPR-authorized As part of the authorization process under the BPR, our first product range has already been approved: this includes Sterillium® pure, which received its authorization in October 2025. This colourant- and fragrance-free hand disinfectant can be used in all areas where hygiene is important and is suitable for people with sensitive skin, asthma or atopic conditions. Its good tolerability has been confirmed by the independent ECARF Institute. The first milestone is Sterillium® pure. The BPR-approved portfolio will gradually expand to include further products in 2027. 13
RkJQdWJsaXNoZXIy NDU5MjM=